Literature DB >> 21680796

IL-7R expression and IL-7 signaling confer a distinct phenotype on developing human B-lineage cells.

Sonja E Nodland1, Magdalena A Berkowska, Anna A Bajer, Nisha Shah, Dick de Ridder, Jacques J M van Dongen, Tucker W LeBien, Menno C van Zelm.   

Abstract

IL-7 is an important cytokine for lymphocyte differentiation. Similar to what occurs in vivo, human CD19⁺ cells developing in human/murine xenogeneic cultures show differential expression of the IL-7 receptor α (IL-7Rα) chain (CD127). We now describe the relationship between CD127 expression/signaling and Ig gene rearrangement. In the present study, < 10% of CD19CD127⁺ and CD19CD127⁻ populations had complete VDJ(H) rearrangements. IGH locus conformation measurements by 3D FISH revealed that CD127⁺ and CD127⁻ cells were less contracted than pediatric BM pro-B cells that actively rearrange the IGH locus. Complete IGH rearrangements in CD127⁺ and CD127⁻ cells had smaller CDR3 lengths and fewer N-nucleotide insertions than pediatric BM B-lineage cells. Despite the paucity of VDJ(H) rearrangements, microarray analysis indicated that CD127⁺ cells resembled large pre-B cells, which is consistent with their low level of Ig light-chain rearrangements. Unexpectedly, CD127⁻ cells showed extensive Ig light-chain rearrangements in the absence of IGH rearrangements and resembled small pre-B cells. Neutralization of IL-7 in xenogeneic cultures led to an increase in Ig light-chain rearrangements in CD127⁺ cells, but no change in complete IGH rearrangements. We conclude that IL-7-mediated suppression of premature Ig light-chain rearrangement is the most definitive function yet described for IL-7 in human B-cell development.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21680796      PMCID: PMC3162350          DOI: 10.1182/blood-2010-08-302513

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

Review 1.  The RAG proteins and V(D)J recombination: complexes, ends, and transposition.

Authors:  S D Fugmann; A I Lee; P E Shockett; I J Villey; D G Schatz
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells.

Authors:  W J Romanow; A W Langerak; P Goebel; I L Wolvers-Tettero; J J van Dongen; A J Feeney; C Murre
Journal:  Mol Cell       Date:  2000-02       Impact factor: 17.970

Review 3.  Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling.

Authors:  Sebastian Herzog; Michael Reth; Hassan Jumaa
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

4.  IL-7 Dependence in human B lymphopoiesis increases during progression of ontogeny from cord blood to bone marrow.

Authors:  Yasmin Khan Parrish; Ineavely Baez; Terry-Ann Milford; Abigail Benitez; Nicholas Galloway; Jaqueline Willeman Rogerio; Eva Sahakian; Mercy Kagoda; Grace Huang; Qian-Lin Hao; Yazmar Sevilla; Lora W Barsky; Ewa Zielinska; Mary A Price; Nathan R Wall; Sinisa Dovat; Kimberly J Payne
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

5.  BCL6 is critical for the development of a diverse primary B cell repertoire.

Authors:  Cihangir Duy; J Jessica Yu; Rahul Nahar; Srividya Swaminathan; Soo-Mi Kweon; Jose M Polo; Ester Valls; Lars Klemm; Seyedmehdi Shojaee; Leandro Cerchietti; Wolfgang Schuh; Hans-Martin Jäck; Christian Hurtz; Parham Ramezani-Rad; Sebastian Herzog; Hassan Jumaa; H Phillip Koeffler; Ignacio Moreno de Alborán; Ari M Melnick; B Hilda Ye; Markus Müschen
Journal:  J Exp Med       Date:  2010-05-24       Impact factor: 14.307

6.  Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development.

Authors:  Stephen Malin; Shane McManus; César Cobaleda; Maria Novatchkova; Alessio Delogu; Philippe Bouillet; Andreas Strasser; Meinrad Busslinger
Journal:  Nat Immunol       Date:  2009-11-29       Impact factor: 25.606

7.  IL-7 activates the phosphatidylinositol 3-kinase/AKT pathway in normal human thymocytes but not normal human B cell precursors.

Authors:  Sonja E Johnson; Nisha Shah; Anna A Bajer; Tucker W LeBien
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

8.  Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy.

Authors:  Claude Sportès; Rebecca R Babb; Michael C Krumlauf; Frances T Hakim; Seth M Steinberg; Catherine K Chow; Margaret R Brown; Thomas A Fleisher; Pierre Noel; Irina Maric; Maryalice Stetler-Stevenson; Julie Engel; Renaud Buffet; Michel Morre; Robert J Amato; Andrew Pecora; Crystal L Mackall; Ronald E Gress
Journal:  Clin Cancer Res       Date:  2010-01-12       Impact factor: 12.531

9.  Foxo1 directly regulates the transcription of recombination-activating genes during B cell development.

Authors:  Rupesh H Amin; Mark S Schlissel
Journal:  Nat Immunol       Date:  2008-05-11       Impact factor: 25.606

10.  Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation.

Authors:  Hart S Dengler; Gisele V Baracho; Sidne A Omori; Shane Bruckner; Karen C Arden; Diego H Castrillon; Ronald A DePinho; Robert C Rickert
Journal:  Nat Immunol       Date:  2008-11-02       Impact factor: 25.606

View more
  13 in total

1.  Increased sensitivity of BCR-ABL-induced B-ALL to imatinib by releasing leukemia B cell differentiation blockage.

Authors:  Zi Wang; Yong Li; Xiaokai Lu; Jia Yuan; Qiang Qiu; Cong Pan
Journal:  Int J Clin Exp Pathol       Date:  2020-11-01

Review 2.  It Takes Three Receptors to Raise a B Cell.

Authors:  Kaitlin C McLean; Malay Mandal
Journal:  Trends Immunol       Date:  2020-05-22       Impact factor: 16.687

Review 3.  Interleukin 7 and thymic stromal lymphopoietin: from immunity to leukemia.

Authors:  Noa Tal; Chen Shochat; Ifat Geron; Dani Bercovich; Shai Izraeli
Journal:  Cell Mol Life Sci       Date:  2013-04-27       Impact factor: 9.261

Review 4.  IL-7 in human health and disease.

Authors:  Wangko Lundström; Natasha M Fewkes; Crystal L Mackall
Journal:  Semin Immunol       Date:  2012-03-10       Impact factor: 11.130

5.  Circulating Human CD27-IgA+ Memory B Cells Recognize Bacteria with Polyreactive Igs.

Authors:  Magdalena A Berkowska; Jean-Nicolas Schickel; Christina Grosserichter-Wagener; Dick de Ridder; Yen Shing Ng; Jacques J M van Dongen; Eric Meffre; Menno C van Zelm
Journal:  J Immunol       Date:  2015-07-06       Impact factor: 5.422

6.  Computational Modeling of a Transcriptional Switch Underlying B-Lymphocyte Lineage Commitment of Hematopoietic Multipotent Cells.

Authors:  Luca Salerno; Carlo Cosentino; Giovanni Morrone; Francesco Amato
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

7.  Dysregulated signaling, proliferation and apoptosis impact on the pathogenesis of TCRγδ+ T cell large granular lymphocyte leukemia.

Authors:  Martine J Kallemeijn; Dick de Ridder; Joyce Schilperoord-Vermeulen; Michèle Y van der Klift; Yorick Sandberg; Jacques J M van Dongen; Anton W Langerak
Journal:  PLoS One       Date:  2017-04-13       Impact factor: 3.240

8.  Insulin-InsR signaling drives multipotent progenitor differentiation toward lymphoid lineages.

Authors:  Pengyan Xia; Shuo Wang; Ying Du; Guanling Huang; Takashi Satoh; Shizuo Akira; Zusen Fan
Journal:  J Exp Med       Date:  2015-11-16       Impact factor: 14.307

9.  Decreased IL7Rα and TdT expression underlie the skewed immunoglobulin repertoire of human B-cell precursors from fetal origin.

Authors:  Magdalena B Rother; Kristin Jensen; Mirjam van der Burg; Fleur S van de Bovenkamp; Roel Kroek; Wilfred F J van IJcken; Vincent H J van der Velden; Tom Cupedo; Ole K Olstad; Jacques J M van Dongen; Menno C van Zelm
Journal:  Sci Rep       Date:  2016-09-23       Impact factor: 4.379

10.  Nuclear positioning rather than contraction controls ordered rearrangements of immunoglobulin loci.

Authors:  Magdalena B Rother; Robert-Jan Palstra; Suchit Jhunjhunwala; Kevin A M van Kester; Wilfred F J van IJcken; Rudi W Hendriks; Jacques J M van Dongen; Cornelis Murre; Menno C van Zelm
Journal:  Nucleic Acids Res       Date:  2015-09-17       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.